Pharma major Lupin has delivered double-digit revenue growth in the September quarter, but a sharp rise in expenses weighed ...

Biocon Limited reported consolidated operating revenue of Rs 4,389 crore for the second quarter of FY27, up 2% year-on-year ...

Aurobindo Pharma has posted its highest-ever quarterly revenue of Rs 10,263 crore for the second quarter of FY27, registering ...

Alembic Pharmaceuticals Limited reported a massive 81% year-on-year surge in consolidated profit after tax (PAT) to Rs. 335 ...

Sevabertinib is an oral, reversible, small-molecule tyrosine kinase inhibitor (TKI) designed to target HER2-activating ...

Novo Nordisk has raised its full-year 2026 outlook for adjusted sales and operating profit following a stronger-than-expected ...

The expanded collaboration combines DifGen’s development and US manufacturing capabilities with Alembic’s established US ...

Updated Phase 1 TRIgnite-1 data includes longer follow-up and early dose-expansion results for heavily pretreated multiple ...

EPL Limited has delivered a blockbuster performance in the second quarter of FY27, posting a 30% year-on-year jump in revenue to Rs 15,674 million, as strong growth across geographies and product ...

Zydus Lifesciences has reported a 29% year-on-year jump in revenue from operations to Rs 79,096 million for the second quarter of FY27, even as profitability weakened, with EBITDA declining 6% and net ...

Bright Minds Biosciences has suffered a regulatory setback after the US Food and Drug Administration (FDA) placed a partial ...

BASF is stepping up its push into next-generation beauty and skincare innovation with the launch of Lincare, a naturally ...